Bioactive Compounds
-
BA1955 IMB-301Summary: IMB-301 is a specific replication inhibitor. - BA1954 ZinlirvimabSummary: Zinlirvimab is a human IgG1-λ2 neutralizing antibody.
- BA1953 PirmitegravirSummary: Pirmitegravir is a potent, first-in-class inhibitor targeting the LEDGF/p75 binding site.
- BA1952 4-Deoxy-4α-phorbolSummary: 4-Deoxy-4α-phorbol is a tetracyclic diterpene.
- BA1951 DPC-681Summary: DPC-681 is a potent and selective HIVprotease inhibitor.
- BA1950 SARS-CoV-IN-3Summary: SARS-CoV-IN-3 is a potent replication inhibitor.
- BA1949 SARS-CoV-IN-2Summary: SARS-CoV-IN-2 is a potent replication inhibitor.
- BA1948 2-Deoxy-2-fluoroarabinoadenosineSummary: 2'-Deoxy-2'-fluoroarabinoadenosine is a nucleoside analog.
- BA1947 ClaficapavirSummary: Claficapavir (A1752) is a specific inhibitor of nucleocapsid proteins at approximately 1 μM.
- BA1946 RN-18Summary: RN-18 is an antagonist of HIV-1 viral infectious factor.